![]() |
|
|
Vol. 295, Issue 3, 889-895, December 2000
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis,
Indiana
Fibroblast growth factor (FGF) has been shown to protect tissue damage
in animal models of cerebral and myocardial ischemia. The cellular and
molecular mechanisms of FGF effects have not been fully defined. In the
present study, we have investigated the effect of FGF homologs on
nitric oxide (NO)-mediated neuronal cell death. Addition of NO donor
S-nitroso-N-acetylpenicillamine (SNAP) to
cultures of human neuroblastoma SHSY-5Y cells resulted in a
concentration-dependent cell death. TdT-mediated dUTP-X nick end
labeling and oligonucleosome assays confirmed that NO-mediated cell death occurred through the apoptotic pathway. In the presence of
150 µM SNAP, about 40% of the cells in culture underwent apoptosis. Treatment with FGF-2 resulted in greater than 80% reduction in NO-induced cell death. FGF addition to cell cultures also enhanced cell
survival without affecting cell proliferation. FGF-2 effectively inhibited NO-mediated apoptosis even when added 6 h after
treatment with SNAP. Examination of other homologs of FGF on
NO-mediated cell death showed that in SHSY-5Y cells, FGF-2 and FGF-4,
but not other FGF homologs, inhibited NO-mediated apoptosis. These results show that FGF-2 was a potent cell survival factor and protected
SHSY-5Y cells from NO-mediated apoptosis. These effects were limited to
FGF-2 and FGF-4 homologs.
This article has been cited by other articles:
![]() |
T. Khomenko, S. Szabo, X. Deng, M. R. Jadus, H. Ishikawa, K. Osapay, Z. Sandor, and L. Chen Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1211 - G1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. A. Meij, F. Sheikh, S. K. Jimenez, P. W. Nickerson, E. Kardami, and P. A. Cattini Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H547 - H555. [Abstract] [Full Text] [PDF] |
||||